Currently, the only practical way to treat type 1 and advanced insulin-dependent type 2 diabetes mellitus (T1/2DM) is the frequent subcutaneous injection of insulin, which is significantly different physiologically from endogenous insulin secretion from pancreatic islets and can lead to hyperinsu-linemia, pain, and infection in patients with poor compliance. Hence, oral insulin delivery has been actively pursued to revolutionize the treatment of insulin-dependent diabetes. In this review, we provide an overview of recent progress in developing poly(lactic co-glycolic acid) (PLGA) nanoparticles (NPs) for oral insulin delivery. Different strategies for insulin-loaded PLGA NPs to achieve normo-glycemic effects are discussed. Finally, challenges and future perspectives of PLGA NPs for oral insulin delivery are put forward.
机构:
Univ Sultan Zainal Abidin, Fac Pharm, Besut Campus, Terengganu 22200, MalaysiaUniv Sultan Zainal Abidin, Fac Pharm, Besut Campus, Terengganu 22200, Malaysia
Seyam, Salma
Nordin, Norsyafikah Asyilla
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sultan Zainal Abidin, Fac Pharm, Besut Campus, Terengganu 22200, MalaysiaUniv Sultan Zainal Abidin, Fac Pharm, Besut Campus, Terengganu 22200, Malaysia
Nordin, Norsyafikah Asyilla
Alfatama, Mulham
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sultan Zainal Abidin, Fac Pharm, Besut Campus, Terengganu 22200, MalaysiaUniv Sultan Zainal Abidin, Fac Pharm, Besut Campus, Terengganu 22200, Malaysia